En Banc Activity / Petitions

Recent En Banc Activity

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include four new petitions related to administrative law, enablement, collateral estoppel, and the doctrine of equivalents; two responses to petitions related to patent eligibility and transfer; one new amicus brief in support of a petition concerning non-obviousness; and the denial of three petitions related to non-obviousness, enablement, written description, and statutory experimental use. Here are the details.

Read More
En Banc Activity / Petitions

Recent En Banc Activity

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include one new petition related to obviousness, one response to a petition related to design patents, two requests for responses to petitions related to Arthrex and transfer, two amicus briefs in support of petitions related to the written description and enablement requirements, and the denial of one petition related to Arthrex and obviousness. Here are the details.

Read More
En Banc Activity / Petitions

Recent En Banc Activity

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include four new petitions, responses to petitions in two cases (including three responses in Arthrex, Inc. v. Smith & Nephew, Inc.), and the denial of a petition along with a dissenting opinion in the same case. Here are the details.

Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report includes a New York Times article highlighting the Federal Circuit’s holding last Thursday that the appointment of the Patent Trial and Appeal Board’s judges is unconstitutional, a comment by the Brookings Institution on the Moda Health Plan, Inc. v. United States case pending before the Supreme Court, and a report by Bloomberg News on the Federal Circuit’s affirming of a trial court decision tossing a $2.5 billion verdict against Gilead Sciences Inc. in a patent case.

Read More
Opinions

Today’s Opinions – October 30, 2019

Today the Federal Circuit issued two precedential opinions in patent cases and one nonprecedential opinion in a patent case. Here are the introductions to the opinions.

Read More